相关实验视频

Updated: Mar 16, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

重新审视心脏性休克:从血动力学中心到多模式精密护理

Xuanqi An¹, Chengliang Yin², Haobo Xu¹

¹Emergency Department, National Clinical Research Center of Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 100037 Beijing, China; State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 100037 Beijing, China; National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences, 100037 Beijing, China.

Trends in cardiovascular medicine

|March 14, 2026

概括

心脏性休克 (CS) 是一种复杂的疾病,死亡率高. 目前以血液动力学为重点的治疗方法不足,需要转向针对炎症和微循环功能障碍的精密护理.

科学领域:

心脏病学心脏病学
关键护理医学关键护理医学
翻译研究是翻译研究.

背景情况:

心脏性休克 (CS) 是一个重大的临床挑战,尽管支持性治疗的进展,但短期死亡率很高.
目前对CS的诊断和治疗策略主要以血液动力学为重点,限制了患者结果的改善.
新出现的证据强调了炎症,微循环功能障碍,内皮损伤和代谢障碍在CS进展中的关键作用.

研究的目的:

重新评估心脏性休克的概念演变.
检查血液动力学中心方法在诊断和治疗CS.的局限性.
倡导转向多式模式精确护理心脏性休克的范式转变.

主要方法:

对CS的历史和当代定义和分阶段系统的审查.
对当前证据分析,其中涉及CS的炎症和微循环因素.
探索新的诊断方式,包括床边微循环评估,奥米克,高级心声回声和人工智能.

主要成果:

以血液动力学为中心的策略并没有显著改善CS结果.
炎症激活,微循环功能障碍和代谢障碍是CS器官衰竭的关键驱动因素.
多模式诊断方法为早期识别和精确分类CS提供了潜力.

结论:

心脏性休克应该被视为一种动态的多系统性疾病,而不是仅仅是血液动力学的问题.
转向多模式精准护理,整合各种诊断工具,对于改善CS管理至关重要.
未来的临床试验和管理策略必须采用更全面的,基于系统的方法来治疗心脏性休克.

关键词:

人工智能的人工智能是人工智能.心脏发生的冲击是心脏的冲击.诊断诊断诊断诊断诊断炎症炎症是一种炎症.微循环是一种微循环.多种组合的多种组合.

更多相关视频

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Real-time Pressure-volume Analysis of Acute Myocardial Infarction in Mice

Real-time Pressure-volume Analysis of Acute Myocardial Infarction in Mice

Published on: July 2, 2018

相关概念视频

Cardiopulmonary Resuscitation IV: Pharmacological Management

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...

Blood Pressure Imbalances and Circulatory Shock

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

Acute Coronary Syndrome IV: Interprofessional Care

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...